Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.43 |
| ▸ | CTSA | P10619 | 12/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL543882 | 0.94 | APLNR (0.47) | APLNRCTSA | |
| SCHEMBL4042192 | 0.92 | APLNR (0.36) | APLNRCTSALPAR1 | |
| SCHEMBL545144 | 0.90 | LPAR1 (0.45) | CTSALPAR1 | |
| Hydrochloric Acid SCHEMBL544277 | 0.89 | LPAR1 (0.44) | CTSALPAR1 | |
| SCHEMBL544463 | 0.89 | LPAR1 (0.43) | CTSALPAR1 | |
| SCHEMBL4042399 | 0.85 | LPAR1 (0.40) | CTSALPAR1 | |
| Hydrochloric Acid SCHEMBL544731 | 0.83 | LPAR1 (0.41) | LPAR1 | |
| Hydrochloric Acid SCHEMBL4041078 | 0.83 | CTSA (0.35) | CTSA | |
| Hydrochloric Acid SCHEMBL544970 | 0.82 | NTSR1 (0.41) | CTSA | |
| SCHEMBL544724 | 0.82 | LPAR1 (0.37) | CTSALPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2059508-A1 | 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS | Sanofi-Aventis (FR) | 2009-05-20 | — | — | EP | disclosed |
| WO-2008020124-A1 | 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS | SANOFI-AVENTIS (FR) | 2008-02-21 | — | — | WO | disclosed |